Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Interventional 266 Observational 1

Sponsor

Cancer Type

Breast 26 Gastrointestinal 24 CNS 23 Head & Neck 20 Genitourinary 19 Thoracic 16 Gynecologic 8 Tumor-Agnostic 5 Sarcoma 5 Other 1 Lymphoid 1 Endocrine 1 Dermatologic 1 Classical hematology 1

Conditions

Hodgkin Disease 1

Interventions

Rituximab 29 Surveys and Questionnaires 25 Blood Specimen Collection 17 Gene Expression Profiling 15 Flow Cytometry 14 Polymerase Chain Reaction 13 Amplified Fragment Length Polymorphism Analysis 13 Microarray Analysis 11 Observation 10 Interviews as Topic 10 Psychiatric Rehabilitation 9 Lenalidomide 9 Immunohistochemistry 9 Cytogenetic Analysis 9 obinutuzumab 8 Watchful Waiting 8 Therapeutics 8 ibrutinib 7 Drug Therapy 7 Cyclophosphamide 7 Bendamustine Hydrochloride 7 Vincristine 6 Prednisone 6 Magnetic Resonance Spectroscopy 6 fludarabine 5 In Situ Hybridization, Fluorescence 5 Immunologic Techniques 5 Data Collection 5 Biopsy 5 zanubrutinib 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × Radiotherapy × Lymphoid × Clear all

NCT04419441 2020-09-16

ICI-RT-1

Ospedale Maggiore Di Trieste

Hodgkin Disease

Data powered by HemOnc (CC BY 4.0) Colophon ⚡